<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04047498</url>
  </required_header>
  <id_info>
    <org_study_id>230144</org_study_id>
    <nct_id>NCT04047498</nct_id>
  </id_info>
  <brief_title>Alternating DBS for Stepping Control in Parkinson's Disease</brief_title>
  <official_title>Studying Stepping Control in Parkinson's Disease Using Alternating DBS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease (PD) is a disabling, progressive condition characterised by severe
      problems with movement for which medical treatment in the longer term can be unsatisfactory.
      Deep brain stimulation (DBS) is a treatment, which directly stimulates the nerve cells
      affected inside the brain to help overcome the difficulties with movement. Classically, DBS
      stimulates in a manner that is constant. Many patients develop severe problems with walking,
      so-called freezing of gait, which can be unresponsive to constant DBS. In this study the
      investigators will test if left-right alternating DBS helps to improve gait problems by
      potentially promoting left-right alternating up- and down-modulated brain activity, which was
      found during walking in a previous study. The investigators will test if alternating DBS
      improves the ability to adjust walking speed and to walk freely compared to constant DBS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Participants and the UPDRS examiner are blinded to the stimulation condition.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stepping control will be assessed as the ability to adjust the stepping speed (m/s) in each stimulation condition.</measure>
    <time_frame>Immediate recording</time_frame>
    <description>Stepping speed (m/s) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stepping control will be assessed as the ability to limit the variance in stepping speed (m/s) in each stimulation condition.</measure>
    <time_frame>Immediate recording</time_frame>
    <description>Stepping variance (m/s) will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The investigators will test if patients automatically adjust to the stimulation rhythm</measure>
    <time_frame>Immediate recording</time_frame>
    <description>Stepping entrainment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will how well other motor symptoms including tremor, rigidity and bradykinesia are controlled with alternating DBS.</measure>
    <time_frame>Immediate recording</time_frame>
    <description>United Parkinsons Disease Rating Scale motor (Part III) scores will be compared between stimulation conditions.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Within-subjects comparison of constant and alternating DBS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alternating DBS</intervention_name>
    <description>Constant DBS will be changed to DBS that is up- and downmodulated alternating between the left and right stimulation side.</description>
    <arm_group_label>Within-subjects comparison of constant and alternating DBS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PD patients with bilateral subthalamic nucleus DBS electrodes and stimulators
             implanted for at least 6 months

          -  Able to give consent.

        Exclusion Criteria:

          -  Lack of capacity to consent

          -  Cognitive impairment/lack of capacity to perform experimental task. The investigators
             will additionally conduct a short (10 min) quantitative assessment of cognitive
             function using a validated test (MMSE). Patients with a score &lt; 20 will be excluded
             from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Brown, MD</last_name>
    <phone>01865 572 482</phone>
    <email>peter.brown@ndcn.ox.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University College London Hospitals NHS Trust</name>
      <address>
        <city>London</city>
        <zip>WC1N 3BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Foltynie, MD PhD</last_name>
      <phone>0845 155 5000</phone>
      <email>t.foltynie@ucl.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oxford</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Fischer P, Chen CC, Chang YJ, Yeh CH, Pogosyan A, Herz DM, Cheeran B, Green AL, Aziz TZ, Hyam J, Little S, Foltynie T, Limousin P, Zrinzo L, Hasegawa H, Samuel M, Ashkan K, Brown P, Tan H. Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping. J Neurosci. 2018 May 30;38(22):5111-5121. doi: 10.1523/JNEUROSCI.3596-17.2018. Epub 2018 May 14.</citation>
    <PMID>29760182</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 1, 2019</study_first_submitted>
  <study_first_submitted_qc>August 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymised data will be made available at https://data.mrc.ox.ac.uk/ once collected and fully analysed</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Anonymised data will be made available at https://data.mrc.ox.ac.uk/ once collected and fully analysed</ipd_time_frame>
    <ipd_access_criteria>Please see https://data.mrc.ox.ac.uk/</ipd_access_criteria>
    <ipd_url>http://data.mrc.ox.ac.uk/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

